SBIR TOPIC 313: RNAI CANCER THERAPEUTICS USING NANOTECHNOLOGY. PHASE I. HHSN26120

Avidity Nanomedicines, Llc, La Jolla CA

Investigators

Abstract

The design, fabrication, characterization, and preclinical evaluation of novel nanoparticle-based drug formulations capable of delivering candidate RNAi therapeutics for the treatment of cancer.